Sylvania, OH, United States of America

James E Gano

This inventor holds 3 USPTO granted patents. Top assignees: Geneva Pharmaceuticals, Inc., The University of Toledo. Active years: 1998-2004.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Sylvania, OH (US) (1998 - 2003)
  • Fort Collins, CO (US) (2004)

Company Filing History:


Years Active: 1998-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of James E. Gano

Introduction

James E. Gano is an accomplished inventor based in Sylvania, Ohio. He has made significant contributions to the field of pharmaceuticals, holding a total of three patents. His work focuses on novel crystal forms of pharmaceutical compounds, which can enhance their effectiveness and usability.

Latest Patents

Among his latest patents is the modification of olanzapine, a pharmaceutical compound used to treat various mental health conditions. This patent discloses a novel crystal form of olanzapine, along with processes for its preparation and pharmaceutical applications. Another notable patent involves a new crystal form of α-dimethyl-4-{1-hydroxy-4-{4-(hydroxydiphenylmethyl)-1-piperidinyl}butyl}benzeneacetic acid hydrochloride, detailing its preparation and uses in the pharmaceutical industry.

Career Highlights

James has worked with reputable organizations such as Geneva Pharmaceuticals, Inc. and the University of Toledo. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Throughout his career, James has collaborated with notable professionals in the field, including Julian Davies and Padmanabhan Sekher. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

James E. Gano's contributions to pharmaceutical innovation through his patents and collaborations highlight his significant role in advancing medical science. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…